Neuraxpharm Belgium SRL

4.8 FTE

Neuraxpharm Belgium reported revenue of €3.72m for the 2025 financial year (annual accounts filed with the NBB on 27 Oct 2026), with 4.8 full-time equivalents.

By total assets for 2025, Neuraxpharm Belgium ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0793.136.336 · VAT BE0793136336
1210 Saint-Josse-ten-Noode
active in Wholesale of pharmaceutical and medical goods (NACE 46460)
operating since 28 Oct 2022 (≈ 4 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Neuraxpharm Belgium shows with a free account.

See the score
Profile
SRL Micro · 4.8 FTE since 2022
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Revenue€3.72m
Net result−363,597 €
Equity−958,982 €
Cash587,196 €
EBITDA−201,914 €
Total assets€3.11m
Headcount (avg FTE)4.8
Solvency-30.9%
The line marks its sector median: 32.3% (146 companies).

Change 2022 → 2025: Total assets +55242 %

Accounts of the company itself (not consolidated).

The full file covers 4 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Neuraxpharm Belgium's annual accounts

2025202420232022
Revenue€3.72m
Net result−363,597 €
Equity−958,982 €
Cash587,196 €
EBITDA−201,914 €
Total assets€3.11m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 27 Oct 2026
  • Year ended 31 Dec 2024filed on 11 Feb 2026
  • Year ended 31 Dec 2023filed on 16 Sep 2024
  • Year ended 31 Dec 2022filed on 27 Jul 2023

Neuraxpharm Belgium's financial analysis

Management and control of Neuraxpharm Belgium

2 active director(s) in the register.

Neuraxpharm Belgium's shareholders and holdings →

Neuraxpharm Belgium's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0793.136.336
VAT number
BE0793136336
Peppol
Registered · 0208:0793136336 · as of 11 Nov 2026
Legal form
SRL
Incorporated
28 Oct 2022
Registered office
1210 Saint-Josse-ten-Noode
Size
Micro · 4.8 FTE
Latest accounts
2025 · filed on 27 Oct 2026
Activity
Wholesale of pharmaceutical and medical goods (NACE 46460)

Neuraxpharm Belgium (SRL) has been based in Saint-Josse-ten-Noode since 2022, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €3.72m, a net loss of 363,597 € and equity of −958,982 €. With 4.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -30.9%, below the median of its sector (32.3%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Neuraxpharm Belgium

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Neuraxpharm Belgium

What is the revenue of Neuraxpharm Belgium?

According to the 2025 annual accounts filed with the NBB, the revenue of Neuraxpharm Belgium amounts to 3,717,080 €.

What is the VAT number of Neuraxpharm Belgium?

In Belgium, the VAT number is the company number prefixed with BE: BE0793136336 for Neuraxpharm Belgium, if the company is VAT-registered. Its company number (CBE) is 0793.136.336.

Where is the registered office of Neuraxpharm Belgium?

According to the CBE register, the registered office of Neuraxpharm Belgium is in 1210 Saint-Josse-ten-Noode.

What is the equity of Neuraxpharm Belgium?

At the close of the 2025 financial year, the equity of Neuraxpharm Belgium amounts to -958,982 €, a solvency of -30.9% of total assets.

How many people work at Neuraxpharm Belgium?

4.8 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Neuraxpharm Belgium?

The register lists 2 active mandates at Neuraxpharm Belgium. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Neuraxpharm Belgium within its sector?

By total assets for 2025, Neuraxpharm Belgium ranks in the top half of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.

Idonis

The full file of Neuraxpharm Belgium

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 05 Nov 2026

No credit card, no commitment.

What each plan unlocks →